Balloon-occluded Alternative Infusion of Fragmented Gelatin Particles of TACE for Hepatocellular Carcinoma Refractory to Atezolizumab-Bevacizumab
Anticancer Research · 2026-07 · 46 (7) · 3897-3906
DOI: 10.21873/anticanres.18251 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Anticancer Research, online erschienen am 29.06.2026. Verfasst von Naoyuki Hasegawa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan; naoyuki-hasegawa@md.tsukuba.ac.jp. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Balloon Occlusion, Bevacizumab.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan; naoyuki-hasegawa@md.tsukuba.ac.jp.
- Department of Radiology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
- Department of Gastroenterology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
- Department of Radiology, Tsukuba Memorial Hospital, Tsukuba, Japan.
- Diagnostic Imaging Department, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
- Department of Radiology, Tsuchiura Kyodo General Hospital, Tsuchiura, Japan.
Zitieren
APA
Hasegawa, N., Hoshiai, S., Yamada, T., Takahashi, N., Mori, K., Mori, K., Fukuda, K., Takizawa, D., Amano, T., Maruo, K., Tsuchiya, K., & Irie, T. (2026). Balloon-occluded Alternative Infusion of Fragmented Gelatin Particles of TACE for Hepatocellular Carcinoma Refractory to Atezolizumab-Bevacizumab. Anticancer Research, 46(7), 3897-3906. https://doi.org/10.21873/anticanres.18251
Vancouver
Hasegawa N, Hoshiai S, Yamada T, Takahashi N, Mori K, Mori K, et al. Balloon-occluded Alternative Infusion of Fragmented Gelatin Particles of TACE for Hepatocellular Carcinoma Refractory to Atezolizumab-Bevacizumab. Anticancer Research. 2026;46(7):3897-3906. doi:10.21873/anticanres.18251
BibTeX
@article{Hasegawa2026,
author = {Hasegawa, Naoyuki and Hoshiai, Sodai and Yamada, Takeshi and Takahashi, Nobuyuki and Mori, Kensaku and Mori, Kouichi and Fukuda, Kuniaki and Takizawa, Daichi and Amano, Taishi and Maruo, Kazushi and Tsuchiya, Kiichiro and Irie, Toshiyuki},
title = {Balloon-occluded Alternative Infusion of Fragmented Gelatin Particles of TACE for Hepatocellular Carcinoma Refractory to Atezolizumab-Bevacizumab},
journal = {Anticancer Research},
year = {2026},
volume = {46},
number = {7},
pages = {3897--3906},
doi = {10.21873/anticanres.18251}
}
EUVIMED